Effects of fullerene C60 nanocomposites on human platelet aggregation.
The effects of fullerene C(60) nanocomposites on human platelet aggregation induced by ADP, ristocetin, and collagen were studied. The nanocomposite containing fullerene C(60) in polyvinyl pyrrolidone solution did not change platelet aggregation, while fullerene C(60) in crown ether and Twin-80 solutions inhibited ADP-induced platelet aggregation by 20 and 30%, respectively.
Military Medical Academy, Ministry of Defense of the Russian Federation, Russia. vladimirvaschenko@yandex.ru
V I
VI
Vaschenko
V V
VV
Samonin
V A
VA
Popov
E V
EV
Antonenkova
V J
VJ
Nikonova
V N
VN
Vilyaninov
M L
ML
Podvjaznikov
V N
VN
Kidalov
T B
TB
Titulova
T N
TN
Vaschenko
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002478:Cells, Cultured; D003094:Collagen / Q000494:pharmacology; D043844:Crown Ethers / Q000737:chemistry; D037741:Fullerenes / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D053761:Nanocomposites / Q000737:chemistry*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011205:Povidone / Q000737:chemistry; D012310:Ristocetin / Q000494:pharmacology; D013501:Surface-Active Agents / Q000737:chemistry
D043844:Crown Ethers; D037741:Fullerenes; D010975:Platelet Aggregation Inhibitors; D013501:Surface-Active Agents; D012310:Ristocetin; D000244:Adenosine Diphosphate; D003094:Collagen; D011205:Povidone; C069837:fullerene C60